Aurogen Overview

  • Founded
  • 1992
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Aurogen General Information

Description

Developer of technology for making pharmaceutical medicines .The company offers pharmaceutical treatment for diabetic neuropathy.

Contact Information

Website
www.aurogen.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • P.O. Box B
  • 202 Remington Street
  • Fort Collins, CO 80522
  • United States
+1 (970) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aurogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2007 0000 Completed Out of Business
1. Later Stage VC 01-Dec-2005 0000 0000 Completed Generating Revenue
To view Aurogen’s complete valuation and funding history, request access »

Aurogen Patents

Aurogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120195959-A1 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin Abandoned 11-Nov-2005 000000000 0
CA-2629294-A1 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin Abandoned 11-Nov-2005 000000000
AU-2006315766-A2 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin Granted 11-Nov-2005 000000000
AU-2006315766-A1 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin Granted 11-Nov-2005 000000000
US-20080248099-A1 Using insulin for making medicine to treat alzheimer's disease, brain atrophy associated with diabetes, parkinson's disease, huntington's disease, senile dementia, multiple sclerosis, dementia associated with acquired immunodeficiency syndrome (aids), pick's disease, stroke, trauma; tolbutamide Abandoned 11-Nov-2005 A61K38/28 0

Aurogen Executive Team (2)

Name Title Board Seat Contact Info
Fred Kerst Ph.D Board Member & Chief Operating Officer
Douglas Ishii Ph.D Founder, Chief Executive Officer & Board Member
To view Aurogen’s complete executive team members history, request access »

Aurogen Board Members (6)

Name Representing Role Since
Collis Woodward Self Board Member 000 0000
Douglas Ishii Ph.D Aurogen Founder, Chief Executive Officer & Board Member 000 0000
Fred Kerst Ph.D Aurogen Board Member & Chief Operating Officer 000 0000
James Brown Self Board Member 000 0000
John Mill Ph.D Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »